Skip to content

Clinical efficacy of Glycolic Acid with Fractional CO2 laser in the treatment of Primary Cutaneous Amyloidosis

Clinical efficacy of Glycolic Acid with Fractional CO2 laser in the treatment of Primary Cutaneous Amyloidosis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024771
Enrollment
Unknown
Registered
2019-07-27
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Cutaneous Amyloidosis

Interventions

Glycolic Acid group:Glycolic Acid peel therapy
Combination therapy group:Glycolic Acid with Fractional CO2 laser

Sponsors

Beijing You'an Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Aged >= 16 years, male or female. Clinical and histopathologic findings were consistent with primary skin amyloidosis. Histopathological examination of skin lesions showed uniform eosinophilic substances without structure by HE staining, and brick red substances by Congo red staining.

Exclusion criteria

Exclusion criteria: (1) allergic to hydroxy acid solution; (2) skin lesions have liquid leakage or combined activities of bacteria, fungi, virus infection; (3) have a history of hypertrophic scar or keloid; (4) distribution of skin skin wrinkles such as perianal, vulva; (5) have serious heart, liver, kidney damage and severe immune dysfunction: (6) before the treatment of the use of corticosteroids and immunosuppressants within 2 weeks; (7) Pregnant or nursing women and those <16 years old; (8) The use of other drugs during treatment affects the observation of the efficacy of this study.

Design outcomes

Primary

MeasureTime frame
Treatment effective rate;

Countries

China

Contacts

Public ContactLi Juan

Beijing Youan Hospital, Capital Medical University

lj_7729579@163.com+86 13552498143

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026